tiprankstipranks
Trending News
More News >
Saibo Co., Ltd. (JP:3123)
:3123
Japanese Market

Saibo Co., Ltd. (3123) AI Stock Analysis

Compare
0 Followers

Top Page

JP:3123

Saibo Co., Ltd.

(3123)

Select Model
Select Model
Select Model
Outperform 72 (OpenAI - 5.2)
Rating:72Outperform
Price Target:
¥801.00
▲(36.22% Upside)
Action:ReiteratedDate:02/18/26
The score is driven primarily by attractive valuation (low P/E and dividend yield) and solid profitability with improving leverage. These positives are moderated by recent revenue contraction and weaker free-cash-flow conversion, while technicals show a strong uptrend but overbought conditions that add near-term risk.
Positive Factors
Resilient profitability
Consistent mid-teens EBIT and double-digit net margins indicate the business retains pricing power and cost control within apparel manufacturing. Durable margins support reinvestment, dividends and resilience across cycles, making operating performance a structural strength despite top-line swings.
Improved leverage
The reduction in leverage materially improves financial flexibility and lowers insolvency risk. A stronger equity base and lower debt ratio provide capacity for strategic investment or downturn buffers, which is important for a cyclical consumer-facing manufacturer over the next several months.
Positive cash generation
Sustained positive operating cash flow and positive FCF provide real cash to fund capex, working capital and shareholder returns. While FCF has declined recently, the current positive cash generation is a durable underpinning for financial stability and optionality over the medium term.
Negative Factors
Revenue contraction
A recent decline in revenue interrupts prior growth momentum and raises structural questions about demand and market share. In apparel manufacturing, sustained top-line weakness can undermine scale economics, restrict margin expansion, and limit ability to fund growth initiatives over coming quarters.
Weaker FCF conversion
Lower free cash flow relative to net income and historical volatility (including negative FCF in 2021–22) signal inconsistent cash conversion. That reduces capacity to deleverage, invest, or smooth dividends and increases sensitivity to working-capital swings in a cyclical sector over the medium term.
Moderate returns & sizeable debt
ROE around 6% suggests limited capital efficiency versus peers, constraining long-term shareholder value creation. Combined with material absolute debt, this leaves the company exposed if demand falls, limiting strategic flexibility and increasing refinancing or interest-rate sensitivity risks.

Saibo Co., Ltd. (3123) vs. iShares MSCI Japan ETF (EWJ)

Saibo Co., Ltd. Business Overview & Revenue Model

Company DescriptionSaibo Co., Ltd. primarily manufactures and sells textile products in Japan and internationally. The company operates through Textile business, Real estate utilization business, and Driving range business segments. It offers apparel products, such as corporate office uniforms, working wear, service wear, jackets, and suits; and novelty and sports-related products. The company also provides textile materials, including rayon filament yarn, polyester yarn, mixed yarn, synthetic cotton, and polyester and linen fabrics, as well as embroidery lace materials. In addition, it involved in the rental of commercial facilities and real estate properties, building maintenance services, as well as golf driving range management activities. Further, the company engages in the provision of repairing services for automobile sheet metal paint products; interior construction and renovation business for general housing, condominiums, factories, and stores.; and sale of new and used vehicles; and insurance and communication equipment. Saibo Co., Ltd. was incorporated in 1948 and is headquartered in Kawaguchi, Japan.
How the Company Makes MoneySaibo Co., Ltd. generates revenue primarily through the sale of its proprietary pharmaceutical products, which include both prescription medications and over-the-counter health solutions. The company also derives income from its contract manufacturing services, providing production capabilities to other companies in the biotech sector. Additionally, Saibo engages in strategic partnerships with research institutions and pharmaceutical companies, allowing it to share development costs and access broader markets. These collaborations often result in milestone payments and royalties, contributing significantly to the company's earnings. Furthermore, Saibo invests in research and development to innovate new products, which can lead to licensing agreements and further revenue opportunities.

Saibo Co., Ltd. Financial Statement Overview

Summary
Solid profitability (TTM gross margin ~25%, net margin ~10%, EBIT margin low-teens) and improved leverage (debt-to-equity ~0.66) support the score. Offsetting factors are a recent revenue decline and weaker/less consistent cash conversion, with TTM free cash flow down materially and covering only about two-thirds of net income.
Income Statement
66
Positive
TTM (Trailing-Twelve-Months) revenue is slightly down versus the prior annual period, following a stronger growth stretch in 2022–2024. Profitability is a clear positive: gross margin is ~25% and net margin is ~10% in TTM, with EBIT margin holding around the low-teens across periods—showing resilient operating performance despite softer top-line momentum. Key weakness is the recent revenue contraction, which raises questions on near-term demand and growth durability.
Balance Sheet
64
Positive
Leverage has improved over time, with debt-to-equity down from above 1.0 in earlier years to ~0.66 in TTM (Trailing-Twelve-Months), which strengthens financial flexibility. Equity has also trended higher versus 2021–2022, supporting the capital base. Returns on equity are moderate (~6% TTM) rather than strong, and total debt remains sizeable in absolute terms, keeping some balance-sheet risk in a cyclical consumer-facing industry.
Cash Flow
61
Positive
Cash generation is positive with TTM (Trailing-Twelve-Months) operating cash flow of ~¥2.4B and free cash flow of ~¥1.2B. However, free cash flow has declined materially in TTM versus the prior year, and free cash flow covers only about two-thirds of net income, indicating less robust cash conversion recently. The historical record shows volatility (including negative free cash flow in 2021–2022), which tempers confidence even though the last few years are improved.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue10.39B10.30B11.42B10.18B8.96B6.73B
Gross Profit2.59B2.70B2.64B2.40B1.86B1.96B
EBITDA2.78B2.71B2.92B2.61B2.20B1.52B
Net Income1.28B859.55M945.72M733.21M499.59M587.76M
Balance Sheet
Total Assets43.01B41.95B43.53B41.85B42.90B39.13B
Cash, Cash Equivalents and Short-Term Investments3.91B3.95B3.64B2.99B2.59B1.82B
Total Debt12.34B12.88B14.00B15.07B16.75B14.80B
Total Liabilities21.19B21.82B23.97B23.67B25.41B22.52B
Stockholders Equity19.36B17.74B17.20B15.97B15.33B14.51B
Cash Flow
Free Cash Flow1.20B1.95B1.94B1.93B-1.06B-10.07B
Operating Cash Flow2.43B2.37B2.27B2.30B2.04B2.14B
Investing Cash Flow-1.24B-627.31M-165.85M-147.64M-2.98B-12.14B
Financing Cash Flow-1.10B-1.48B-1.37B-1.90B1.74B10.07B

Saibo Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price588.00
Price Trends
50DMA
637.30
Positive
100DMA
617.31
Positive
200DMA
573.81
Positive
Market Momentum
MACD
20.10
Positive
RSI
61.71
Neutral
STOCH
61.84
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3123, the sentiment is Positive. The current price of 588 is below the 20-day moving average (MA) of 676.25, below the 50-day MA of 637.30, and above the 200-day MA of 573.81, indicating a bullish trend. The MACD of 20.10 indicates Positive momentum. The RSI at 61.71 is Neutral, neither overbought nor oversold. The STOCH value of 61.84 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3123.

Saibo Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
¥196.10B13.5410.24%2.43%6.08%8.55%
75
Outperform
¥120.03B24.351.79%10.76%54.82%
72
Outperform
¥8.94B7.112.75%-4.76%8.43%
66
Neutral
¥154.04B48.892.34%3.38%>-0.01%-49.83%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
59
Neutral
¥238.39B19.955.31%2.29%-6.04%146.54%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3123
Saibo Co., Ltd.
698.00
239.68
52.30%
JP:3002
Gunze
4,720.00
2,332.36
97.68%
JP:3569
Seiren Co
3,655.00
1,089.81
42.48%
JP:3591
WACOAL HOLDINGS
4,579.00
-389.09
-7.83%
JP:3104
Fujibo Holdings, Inc.
10,820.00
5,883.57
119.19%
JP:8011
Sanyo Shokai Ltd.
4,280.00
1,571.54
58.02%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 18, 2026